Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 8045139.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Limulus anti-lipopolysaccharide factor, an 11.8-kilodalton peptide isolated from amebocytes of Limulus polyphemus inhibits the biologic activities of endotoxin in vitro, including gelation of Limulus amebocyte lysate. A recombinant version of Limulus anti-lipopolysaccharide factor, termed endotoxin neutralizing protein, has now been expressed in yeast. Endotoxin-neutralizing protein was evaluated for its potential prophylactic and therapeutic effects in rabbits challenged with Escherichia coli endotoxin. Controlled animal trial. Animal research laboratory. A total of 112 New Zealand white rabbits were studied. Rabbits were challenged with an LD80 dose of E. coli endotoxin (100 micrograms/kg); control animals (n = 52) were treated with saline solution at the time of endotoxin challenge; experimental animals received endotoxin-neutralizing protein 2.5 mg/kg prechallenge (n = 20), 5.0 mg/kg prechallenge (n = 20), or 5.0 mg/kg 30 mins postchallenge (n = 20).
Medical subject headings
- Anti-Bacterial Agents
- Escherichia coli Infections
- Invertebrate Hormones
- Premedication
- Recombinant Proteins
- Shock, Septic